EUVIMEDEUVIMED entdecken
Open Access

Engineered Bacillus subtilis as Oral Probiotics To Enhance Clearance of Blood Lactate

Mengdi Yang, Noah Hutchinson, Ningyuan Ye, Hania Timek, Maria Jennings, Jianing Yin, Ming Guan, Zongqi Wang, Peiru Chen, Shaobo Yang iD, Justin D Crane, Ke Zhang und 2 weitere

ACS Synthetic Biology · 17.01.2025 · 14 (1) · 101-112

DOI: 10.1021/acssynbio.4c00399 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Synthetic Biology, online erschienen am 31.12.2024. Verfasst von Mengdi Yang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, Northeastern University, Boston, Massachusetts 02115, United States. Hauptthemen laut MEDLINE: Bacillus subtilis, Probiotics, Lactic Acid. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIDCR NIH HHS, NIBIB NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bacillus subtilisProbioticsLactic AcidAnimalsMiceAdministration, OralGastrointestinal MicrobiomeSpores, BacterialMice, Inbred C57BLMixed Function Oxygenases

Stichwörter der Autor:innen

Bacillus subtilislactate elevationlactic acidprobiotics

Substanzen

Lactic Acidlactate 2-monooxygenaseMixed Function Oxygenases

Autor:innen und Institutionen

  • Department of Bioengineering, Northeastern University, Boston, Massachusetts 02115, United States.
  • Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan 48109, United States.
  • Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts 02115, United States.
  • Internal Medicine Research Unit, Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States.
  • Department of Microbiology, The ADA Forsyth Institute, Cambridge, Massachusetts 02142, United States.

ORCID-Profile: Shaobo Yang, Jiahe Li

Förderung

  • NIGMS NIH HHS
  • NIDCR NIH HHS
  • NIBIB NIH HHS
  • U.S. Department of Defense
  • U.S. Department of Health and Human Services

Zitieren

APA

Yang, M., Hutchinson, N., Ye, N., Timek, H., Jennings, M., Yin, J., Guan, M., Wang, Z., Chen, P., Yang, S., Crane, J. D., Zhang, K., He, X., & Li, J. (2025). Engineered Bacillus subtilis as Oral Probiotics To Enhance Clearance of Blood Lactate. ACS Synthetic Biology, 14(1), 101-112. https://doi.org/10.1021/acssynbio.4c00399

Vancouver

Yang M, Hutchinson N, Ye N, Timek H, Jennings M, Yin J, et al. Engineered Bacillus subtilis as Oral Probiotics To Enhance Clearance of Blood Lactate. ACS Synthetic Biology. 2025;14(1):101-112. doi:10.1021/acssynbio.4c00399

BibTeX
@article{Yang2025,
  author = {Yang, Mengdi and Hutchinson, Noah and Ye, Ningyuan and Timek, Hania and Jennings, Maria and Yin, Jianing and Guan, Ming and Wang, Zongqi and Chen, Peiru and Yang, Shaobo and Crane, Justin D and Zhang, Ke and He, Xuesong and Li, Jiahe},
  title = {Engineered Bacillus subtilis as Oral Probiotics To Enhance Clearance of Blood Lactate},
  journal = {ACS Synthetic Biology},
  year = {2025},
  volume = {14},
  number = {1},
  pages = {101--112},
  doi = {10.1021/acssynbio.4c00399}
}
Kostenlos starten →